Truist Securities analyst Naved Khan downgrades Opendoor Technologies (NASDAQ:OPEN) from Buy to Hold.
bioAffinity Technologies News Update, CyPath Lung Sales Ramp Up Month Over Month
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW))) shares recent Company news.CyPath® Lung Sales Ramp Up Month over MonthSales of CyPath® Lung, our noninvasive diagnostic test for the early detection of lung